Home » The pioneer in developing therapeutic filtration devices to handle infectious cancers and disease.

The pioneer in developing therapeutic filtration devices to handle infectious cancers and disease.

Aethlon will disclose the website of the pilot study along with treatment protocols in the arriving months. An in vitro study, beneath the collaboration of Douglas D. Taylor, Ph.D. Dr. An in vitro research, beneath the collaboration of Andrew Raubitschek, M.D. Dr. Raubitschek can be Co-leader for the Cancers Immunotherapeutics Plan at the Comprehensive Cancers Center and Chief of Radioimmunotherapy and Professor, Radiation Oncology at the town of Hope also.. Aethlon Medical programs to initiate individual recruitment for tumor immunotherapy study Aethlon Medical, Inc. , the pioneer in developing therapeutic filtration devices to handle infectious cancers and disease, announced today that it plans to initiate individual recruitment for a malignancy immunotherapy study by calendar year end.Testing empowers patients and their urologists with the given info to make an informed decision. The above statement could be attributed to AUA Recent President John M. Barry, MD. The AUA Greatest Practice Declaration on Prostate-Specific Antigen can be looked at here:.

AGA honors outstanding students with 2011 research fellowship awards The American Gastroenterological Association Research Basis has announced the 2011 Student Study Fellowship Award recipients. Funded by The Edythe and Eli Broad Foundation, the awards are designed to stimulate curiosity in research professions in digestive diseases. ‘At the same time of unparalleled scientific and medical opportunity, these gifted students are critical for the continuing future of gastroenterology study, and essential to the development of new remedies and treatments for digestive diseases,’ said Nicholas F.